Author

S. Provan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Cost-effectiveness of herpes zoster vaccination in patients with rheumatoid arthritis

Abstract Objectives To assess the cost-effectiveness of vaccinating patients with rheumatoid arthritis (RA) with the adjuvanted recombinant zoster vaccine (RZV), compared with no vaccination. Methods To predict health gains and costs from vaccination, we developed a decision-analytic Markov model with five health state...

G. Hagen, Anna K. Opheim, Joakim Overbo et al. · Rheumatology · 0 citations

Sep 2026

Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries.

OBJECTIVES The European Alliance of Associations for Rheumatology (EULAR) recently proposed a framework for 'difficult-to-manage' (D2M) and 'treatment-refractory' disease in psoriatic arthritis (PsA). We explored real-world prevalence and characteristics of patients fulfilling registry-based components inspired by EULA...

L. Nielung, D. di Giuseppe, M. Hetland et al. · Annals of the Rheumatic Dise... · 0 citations